ID RIR1_HHV23 Reviewed; 1144 AA. AC P09853; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1996, sequence version 2. DT 24-JAN-2024, entry version 111. DE RecName: Full=Ribonucleoside-diphosphate reductase large subunit {ECO:0000255|HAMAP-Rule:MF_04026}; DE Short=R1 {ECO:0000255|HAMAP-Rule:MF_04026}; DE EC=1.17.4.1 {ECO:0000255|HAMAP-Rule:MF_04026}; DE AltName: Full=Ribonucleotide reductase large subunit {ECO:0000255|HAMAP-Rule:MF_04026}; GN Name=RIR1 {ECO:0000255|HAMAP-Rule:MF_04026}; OS Human herpesvirus 2 (strain 333) (HHV-2) (Human herpes simplex virus 2). OC Viruses; Duplodnaviria; Heunggongvirae; Peploviricota; Herviviricetes; OC Herpesvirales; Orthoherpesviridae; Alphaherpesvirinae; Simplexvirus; OC Simplexvirus humanalpha2; Human herpesvirus 2. OX NCBI_TaxID=10313; OH NCBI_TaxID=9606; Homo sapiens (Human). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2419588; DOI=10.1128/jvi.57.3.802-808.1986; RA Swain M.A., Galloway D.A.; RT "Herpes simplex virus specifies two subunits of ribonucleotide reductase RT encoded by 3'-coterminal transcripts."; RL J. Virol. 57:802-808(1986). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 981-1144. RX PubMed=6321759; DOI=10.1128/jvi.49.3.724-730.1984; RA Galloway D.A., Swain M.A.; RT "Organization of the left-hand end of the herpes simplex virus type 2 BglII RT N fragment."; RL J. Virol. 49:724-730(1984). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1036-1144. RX PubMed=6315408; DOI=10.1002/j.1460-2075.1983.tb01684.x; RA McLauchlan J., Clements J.B.; RT "DNA sequence homology between two co-linear loci on the HSV genome which RT have different transforming abilities."; RL EMBO J. 2:1953-1961(1983). RN [4] RP REVIEW. RX PubMed=18990579; DOI=10.1016/j.tibs.2008.09.008; RA Lembo D., Brune W.; RT "Tinkering with a viral ribonucleotide reductase."; RL Trends Biochem. Sci. 34:25-32(2009). CC -!- FUNCTION: Ribonucleoside-diphosphate reductase holoenzyme that provides CC the precursors necessary for viral DNA synthesis. Allows virus growth CC in non-dividing cells, as well as reactivation from latency in infected CC hosts. Catalyzes the biosynthesis of deoxyribonucleotides from the CC corresponding ribonucleotides (By similarity). The N-terminal region CC confers antiapoptotic activity in differentiated cells such as neurons CC and is important for viral reactivation to increase neural CC survivability. Prevents host necroptosis by targeting host RIPK1 and CC RIPK3, thereby hampering the formation of necroptotic RIPK1-RIPK3 CC complexes (By similarity). May form hetero-amyloid structures with host CC proteins RIPK3 or ZBP1, thereby preventing RIPK3- and ZBP1-mediated CC necroptosis (By similarity). In addition, inhibits extrinsic apoptosis CC by targeting host CASP8 (By similarity). {ECO:0000250|UniProtKB:P08543, CC ECO:0000250|UniProtKB:P89462, ECO:0000255|HAMAP-Rule:MF_04026}. CC -!- CATALYTIC ACTIVITY: CC Reaction=[thioredoxin]-disulfide + a 2'-deoxyribonucleoside 5'- CC diphosphate + H2O = [thioredoxin]-dithiol + a ribonucleoside 5'- CC diphosphate; Xref=Rhea:RHEA:23252, Rhea:RHEA-COMP:10698, Rhea:RHEA- CC COMP:10700, ChEBI:CHEBI:15377, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058, CC ChEBI:CHEBI:57930, ChEBI:CHEBI:73316; EC=1.17.4.1; CC Evidence={ECO:0000255|HAMAP-Rule:MF_04026}; CC -!- SUBUNIT: Heterotetramer composed of a homodimer of the large subunit CC (R1) and a homodimer of the small subunit (R2). Larger multisubunit CC protein complex are also active, composed of (R1)n(R2)n (By CC similarity). May self-assemble (via RIP homotypic interaction CC motif/RHIM) into homomeric fibrillar amyloid structures (By CC similarity). Interacts (via RHIM) with human RIPK1 (via RHIM). CC Interacts (via RHIM) with human RIPK3 (via RHIM) (By similarity). May CC interact (via RHIM) with human ZBP1 (via RHIM) (By similarity). CC Interacts (via C-terminus) with host CASP8 (By similarity). CC {ECO:0000250|UniProtKB:P08543, ECO:0000250|UniProtKB:P89462, CC ECO:0000255|HAMAP-Rule:MF_04026}. CC -!- DOMAIN: The RIP homotypic interaction motif/RHIM may drive self- CC assembly into homomeric amyloid structures and mediates interaction CC with the RHIM motif of host proteins RIPK3 and ZBP1 to form heteromeric CC amyloid structures. {ECO:0000250|UniProtKB:P08543}. CC -!- SIMILARITY: Belongs to the ribonucleoside diphosphate reductase large CC chain family. {ECO:0000255|HAMAP-Rule:MF_04026}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M12700; AAA45806.1; -; Genomic_DNA. DR EMBL; X00048; CAA24929.1; -; Genomic_DNA. DR SMR; P09853; -. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; IEA:UniProtKB-UniRule. DR GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule. DR GO; GO:0039526; P:perturbation by virus of host apoptosis; IEA:UniProtKB-KW. DR GO; GO:0019046; P:release from viral latency; IEA:UniProtKB-KW. DR GO; GO:0019050; P:suppression by virus of host apoptotic process; IEA:UniProtKB-KW. DR Gene3D; 3.20.70.20; -; 1. DR HAMAP; MF_04026; HSV_RIR1; 1. DR InterPro; IPR034717; HSV_RIR1. DR InterPro; IPR013346; NrdE_NrdA_C. DR InterPro; IPR000788; RNR_lg_C. DR InterPro; IPR013509; RNR_lsu_N. DR InterPro; IPR039718; Rrm1. DR NCBIfam; TIGR02506; NrdE_NrdA; 1. DR PANTHER; PTHR11573; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CHAIN; 1. DR PANTHER; PTHR11573:SF6; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE SUBUNIT; 1. DR Pfam; PF02867; Ribonuc_red_lgC; 1. DR Pfam; PF00317; Ribonuc_red_lgN; 1. DR PRINTS; PR01183; RIBORDTASEM1. DR SUPFAM; SSF51998; PFL-like glycyl radical enzymes; 1. DR PROSITE; PS00089; RIBORED_LARGE; 1. PE 3: Inferred from homology; KW ATP-binding; Disulfide bond; DNA replication; Early protein; KW Host-virus interaction; Inhibition of host caspases by virus; KW Modulation of host cell apoptosis by virus; Nucleotide-binding; KW Oxidoreductase; Viral latency; Viral reactivation from latency. FT CHAIN 1..1144 FT /note="Ribonucleoside-diphosphate reductase large subunit" FT /id="PRO_0000187237" FT REGION 1..33 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 118..324 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 55..75 FT /note="RIP homotypic interaction motif (RHIM)" FT /evidence="ECO:0000250|UniProtKB:P08543" FT COMPBIAS 118..136 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 144..161 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 189..203 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 204..221 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 798 FT /note="Proton acceptor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT ACT_SITE 800 FT /note="Cysteine radical intermediate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT ACT_SITE 802 FT /note="Proton acceptor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT BINDING 573 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT BINDING 588..589 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT BINDING 619 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT BINDING 798..802 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT BINDING 975..979 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT SITE 589 FT /note="Important for hydrogen atom transfer" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT SITE 815 FT /note="Important for hydrogen atom transfer" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT SITE 1118 FT /note="Important for electron transfer" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT SITE 1119 FT /note="Important for electron transfer" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT SITE 1139 FT /note="Interacts with thioredoxin/glutaredoxin" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT SITE 1142 FT /note="Interacts with thioredoxin/glutaredoxin" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" FT DISULFID 589..815 FT /note="Redox-active" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04026" SQ SEQUENCE 1144 AA; 125093 MW; 4771481C3103FC78 CRC64; MANRPAASAL AGARSPSERQ EPREPEVAPP GGDHVFCRKV SGVMVLSSDP PGPAAYRISD SSFVQCGSNC SMIIDGDVAR GHLRDLEGAT STGAFVAISN VAAGGDGRTA VVALGGTSGP SATTSVGTQT SGEFLHGNPR TPEPQGPQAV PPPPPPPFPW GHECCARRDA RGGAEKDVGA AESWSDGPSS DSETEDSDSS DEDTGSGSET LSRSSSIWAA GATDDDDSDS DSRSDDSVQP DVVVRRRWSD GPAPVAFPKP RRPGDSPGNP GLGAGTGPGS ATDPRASADS DSAAHAAAPQ ADVAPVLDSQ PTVGTDPGYP VPLELTPENA EAVARFLGDA VDREPALMLE YFCRCAREES KRVPPRTFGS APRLTEDDFG LLNYALAEMR RLCLDLPPVP PNAYTPYHLR EYATRLVNGF KPLVRRSARL YRILGILVHL RIRTREASFE EWMRSKEVDL DFGLTERLRE HEAQLMILAQ ALNPYDCLIH STPNTLVERG LQSALKYEEF YLKRFGGHYM ESVFQMYTRI AGFLACRATR GMRHIALGRQ GSWWEMFKFF FHRLYDHQIV PSTPAMLNLG TRNYYTSSCY LVNPQATTNQ ATLRAITGNV SAILARNGGI GLCMQAFNDA SPGTASIMPA LKVLDSLVAA HNKQSTRPTG ACVYLEPWHS DVRAVLRMKG VLAGEEAQRC DNIFSALWMP DLFFKRLIRH LDGEKNVTWS LFDRDTSMSL ADFHGEEFEK LYEHLEAMGF GETIPIQDLA YAIVRSAATT GSPFIMFKDA VNRHYIYDTQ GAAIAGSNLC TEIVHPSSKR SSGVCNLGSV NLARCVSRRT FDFGMLRDAV QACVLMVNIM IDSTLQPTPQ CARGHDNLRS MGIGMQGLHT ACLKMGLDLE SAEFRDLNTH IAEVMLLAAM KTSNALCVRG ARPFSHFKRS MYRAGRFHWE RFSNASPRYE GEWEMLRQSM MKHGLRNSQF IALMPTAASA QISDVSEGFA PLFTNLFSKV TRDGETLRPN TLLLKELERT FGGKRLLDAM DGLEAKQWSV AQALPCLDPA HPLRRFKTAF DYDQELLIDL CADRAPYVDH SQSMTLYVTE KADGTLPAST LVRLLVHAYK RGLKTGMYYC KVRKATNSGV FAGDDNIVCT SCAL //